Total Payments
$867.29
2022 Payments
$47.42
Companies
14
Transactions
50
Medicare Patients
3,034
Medicare Billing
$129,209
Payment Breakdown by Category
Food & Beverage$786.54 (90.7%)
Education$80.75 (9.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $786.54 | 48 | 90.7% |
| Education | $80.75 | 2 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Foundation Medicine, Inc. | $199.44 | 6 | $0 (2018) |
| Genentech USA, Inc. | $149.91 | 10 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $123.22 | 11 | $0 (2019) |
| Pharmacyclics LLC, An AbbVie Company | $85.22 | 2 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $59.45 | 4 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $59.37 | 4 | $0 (2019) |
| PFIZER INC. | $46.13 | 4 | $0 (2022) |
| Astellas Pharma US Inc | $33.56 | 2 | $0 (2021) |
| Janssen Biotech, Inc. | $30.29 | 2 | $0 (2019) |
| EMD Serono, Inc. | $18.62 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $47.42 | 3 | GENZYME CORPORATION ($17.92) |
| 2021 | $14.46 | 1 | Astellas Pharma US Inc ($14.46) |
| 2020 | $17.18 | 1 | Genentech USA, Inc. ($17.18) |
| 2019 | $292.90 | 16 | Genentech USA, Inc. ($75.04) |
| 2018 | $256.15 | 15 | Foundation Medicine, Inc. ($93.57) |
| 2017 | $239.18 | 14 | Foundation Medicine, Inc. ($105.87) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2022 | Adaptive Biotechnologies Corporation | — | Food and Beverage | In-kind items and services | $17.86 | General |
| 08/29/2022 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Oncology | ||||||
| 08/15/2022 | PFIZER INC. | INLYTA (Drug), BAVENCIO, LORBRENA | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: ONCOLOGY | ||||||
| 03/12/2020 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: BioOncology | ||||||
| 12/10/2019 | PFIZER INC. | MEKTOVI (Drug), BRAFTOVI | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Education | In-kind items and services | $69.95 | General |
| Category: Oncology | ||||||
| 10/04/2019 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Oncology | ||||||
| 08/29/2019 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: BioOncology | ||||||
| 08/06/2019 | EMD Serono, Inc. | Bavencio (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Oncology | ||||||
| 07/25/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2019 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: BioOncology | ||||||
| 05/01/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: ONCOLOGY | ||||||
| 04/12/2019 | Astellas Pharma US Inc | XOSPATA (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: ONCOLOGY | ||||||
| 03/11/2019 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: BioOncology | ||||||
| 02/27/2019 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: BioOncology | ||||||
| 02/21/2019 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: BioOncology/Immunology | ||||||
| 02/04/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: ONCOLOGY | ||||||
| 01/15/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2018 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $33.41 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2018 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $19.54 | General |
| Category: Oncology | ||||||
| 08/31/2018 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $48.04 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 454 | 950 | $40,924 | $11,404 |
| 2022 | 24 | 915 | 5,134 | $95,428 | $25,245 |
| 2021 | 19 | 582 | 2,635 | $64,824 | $16,840 |
| 2020 | 19 | 1,083 | 5,603 | $270,697 | $75,719 |
Total Patients
3,034
Total Services
14,322
Medicare Billing
$129,209
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 29 | 32 | $11,488 | $3,080 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 27 | $7,695 | $2,597 | 33.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 14 | $2,814 | $882.18 | 31.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 89 | 103 | $2,266 | $783.83 | 34.6% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 19 | 36 | $2,916 | $778.44 | 26.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 14 | 16 | $2,928 | $755.36 | 25.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 64 | 69 | $2,070 | $714.15 | 34.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 62 | 67 | $603.00 | $562.80 | 93.3% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 22 | 39 | $1,677 | $447.97 | 26.7% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 42 | 45 | $945.00 | $266.40 | 28.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 22 | $990.00 | $223.66 | 22.6% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2023 | 18 | 190 | $3,990 | $193.23 | 4.8% |
| 83735 | Magnesium level | Office | 2023 | 14 | 14 | $266.00 | $91.98 | 34.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 22 | 276 | $276.00 | $27.30 | 9.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 72 | $20,520 | $7,004 | 34.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 47 | 64 | $22,931 | $6,460 | 28.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 154 | 211 | $4,431 | $1,614 | 36.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 121 | 146 | $5,110 | $1,518 | 29.7% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 27 | 52 | $4,155 | $1,172 | 28.2% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2022 | 18 | 22 | $3,830 | $1,087 | 28.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 18 | 20 | $3,573 | $1,004 | 28.1% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 38 | 81 | $3,465 | $964.33 | 27.8% |
| 71260 | Ct scan of chest with contrast | Office | 2022 | 15 | 15 | $5,901 | $844.37 | 14.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $2,211 | $616.35 | 27.9% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2022 | 69 | 79 | $1,659 | $470.32 | 28.3% |
About Dr. Alan Berg, MD
Dr. Alan Berg, MD is a Hematology & Oncology healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164412425.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Berg, MD has received a total of $867.29 in payments from pharmaceutical and medical device companies, with $47.42 received in 2022. These payments were reported across 50 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($786.54).
As a Medicare-enrolled provider, Berg has provided services to 3,034 Medicare beneficiaries, totaling 14,322 services with total Medicare billing of $129,209. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Lincoln, NE
- Active Since 10/26/2005
- Last Updated 03/16/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1164412425
Products in Payments
- FOUNDATIONONE (Device) $199.44
- KEYTRUDA (Biological) $123.22
- TECENTRIQ (Biological) $89.67
- Imbruvica (Drug) $85.22
- OPDIVO (Biological) $39.91
- Avastin (Biological) $39.43
- PROMACTA (Drug) $33.63
- IMBRUVICA (Drug) $30.29
- Rituxan (Biological) $20.81
- EMPLICITI (Biological) $19.54
- XOSPATA (Drug) $19.10
- Bavencio (Biological) $18.62
- SARCLISA (Biological) $17.92
- XTANDI (Drug) $14.46
- Neulasta (Biological) $14.27
- AFINITOR (Drug) $13.74
- BOSULIF (Drug) $12.46
- Nerlynx (Drug) $12.03
- TASIGNA (Drug) $12.00
- INLYTA (Drug) $11.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Lincoln
Mr. Steven Dunder, Md, MD
Hematology & Oncology — Payments: $26,199
Hematology & Oncology $26,199
Nathan Green, Do, DO
Hematology & Oncology — Payments: $10,159
Hematology & Oncology $10,159
Wallace Peterson, Md, MD
Hematology & Oncology — Payments: $6,017
Hematology & Oncology $6,017
Melissa Cetak, Aprn, APRN
Hematology & Oncology — Payments: $5,017
Hematology & Oncology $5,017
Dr. Joni Tilford, Md, MD
Hematology & Oncology — Payments: $4,721
Hematology & Oncology $4,721
Dr. Matthew Shupe, D.o, D.O
Hematology & Oncology — Payments: $4,207
Hematology & Oncology $4,207